D.E. Shaw & Co’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,241,928
| Closed | -$228M | – | 5645 |
|
|
2021
Q2 | $228M | Buy |
1,241,928
+162,843
| +15% | +$28M | 0.26% | 89 |
|
|
2021
Q1 | $165M | Buy |
1,079,085
+245,535
| +29% | +$38M | 0.2% | 125 |
|
|
2020
Q4 | $130M | Buy |
833,550
+59,210
| +8% | +$7.61M | 0.16% | 201 |
|
|
2020
Q3 | $88.6M | Buy |
774,340
+457,991
| +145% | +$49.4M | 0.12% | 253 |
|
|
2020
Q2 | $35.5M | Sell |
316,349
-419,804
| -57% | -$44.6M | 0.05% | 501 |
|
|
2020
Q1 | $66.1M | Sell |
736,153
-148,056
| -17% | -$14.5M | 0.13% | 226 |
|
|
2019
Q4 | $95.6M | Sell |
884,209
-752,592
| -46% | -$80.5M | 0.15% | 213 |
|
|
2019
Q3 | $160M | Buy |
1,636,801
+1,372,387
| +519% | +$155M | 0.26% | 96 |
|
|
2019
Q2 | $34.6M | Buy |
264,414
+101,955
| +63% | +$13.1M | 0.05% | 500 |
|
|
2019
Q1 | $22M | Sell |
162,459
-692,264
| -81% | -$86.1M | 0.04% | 684 |
|
|
2018
Q4 | $83.2M | Buy |
854,723
+330,717
| +63% | +$39.1M | 0.15% | 197 |
|
|
2018
Q3 | $72.8M | Sell |
524,006
-67,885
| -11% | -$8.52M | 0.11% | 279 |
|
|
2018
Q2 | $73.5M | Sell |
591,891
-58,472
| -9% | -$6.83M | 0.12% | 258 |
|
|
2018
Q1 | $72.5M | Buy |
650,363
+299,529
| +85% | +$35.8M | 0.12% | 246 |
|
|
2017
Q4 | $42M | Buy |
350,834
+235,075
| +203% | +$28.6M | 0.08% | 408 |
|
|
2017
Q3 | $16.2M | Sell |
115,759
-173,825
| -60% | -$23.6M | 0.03% | 705 |
|
|
2017
Q2 | $35.2M | Buy |
+289,584
| New | +$33.7M | 0.07% | 396 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 3760 |
|
|
2016
Q4 | – | Sell |
-41,144
| Closed | -$5.03M | – | 3720 |
|
|
2016
Q3 | $5.04M | Sell |
41,144
-150,649
| -79% | -$19.4M | 0.01% | 1294 |
|
|
2016
Q2 | $22.4M | Sell |
191,793
-7,732
| -4% | -$1.1M | 0.05% | 512 |
|
|
2016
Q1 | $27.8M | Sell |
199,525
-158,716
| -44% | -$23.3M | 0.06% | 426 |
|
|
2015
Q4 | $68.3M | Sell |
358,241
-130,228
| -27% | -$22.7M | 0.14% | 237 |
|
|
2015
Q3 | $76.4M | Buy |
488,469
+161,903
| +50% | +$29.5M | 0.15% | 215 |
|
|
2015
Q2 | $59M | Buy |
326,566
+304,907
| +1,408% | +$52.6M | 0.11% | 272 |
|
|
2015
Q1 | $3.75M | Sell |
21,659
-135,423
| -86% | -$24.5M | 0.01% | 1564 |
|
|
2014
Q4 | $29.1M | Buy |
157,082
+96,173
| +158% | +$17.8M | 0.06% | 542 |
|
|
2014
Q3 | $10.1M | Sell |
60,909
-112,945
| -65% | -$18.5M | 0.02% | 1076 |
|
|
2014
Q2 | $27.2M | Sell |
173,854
-28,684
| -14% | -$4.53M | 0.06% | 539 |
|
|
2014
Q1 | $30.8M | Buy |
+202,538
| New | +$32.2M | 0.06% | 452 |
|
|
2013
Q4 | – | Sell |
-83,653
| Closed | -$10M | – | 4861 |
|
|
2013
Q3 | $9.72M | Sell |
83,653
-43,218
| -34% | -$4.74M | 0.03% | 1038 |
|
|
2013
Q2 | $11.7M | Buy |
+126,871
| New | +$12.2M | 0.03% | 790 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM